# Quantification of Contrast Enhanced Ultrasound (CEUS) in the Detection of Prostate Cancer

> **NCT01481441** · NA · TERMINATED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 208 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** SonoVue

## Key facts

- **NCT ID:** NCT01481441
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-11
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 208 (ACTUAL)
- **Why stopped:** New study protocol started including targeted biopsies
- **Last updated:** 2016-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01481441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01481441, "Quantification of Contrast Enhanced Ultrasound (CEUS) in the Detection of Prostate Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01481441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*